Beryl Drugs Limited (BERLDRG.BO)
INR 19.55
(-3.65%)
INR 19.55
(-3.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 271.24 Million INR | 1.57% |
| 2022 | 267.05 Million INR | 84.76% |
| 2021 | 144.54 Million INR | 4.42% |
| 2020 | 138.43 Million INR | 10.15% |
| 2019 | 125.67 Million INR | -0.57% |
| 2018 | 126.39 Million INR | -14.36% |
| 2017 | 147.58 Million INR | 36.64% |
| 2016 | 108 Million INR | -17.62% |
| 2015 | 131.1 Million INR | -1.33% |
| 2014 | 132.86 Million INR | -8.96% |
| 2013 | 145.93 Million INR | -0.29% |
| 2012 | 146.35 Million INR | 58.05% |
| 2011 | 92.59 Million INR | 22.86% |
| 2010 | 75.37 Million INR | 8.52% |
| 2009 | 69.45 Million INR | -0.55% |
| 2008 | 69.84 Million INR | 12.18% |
| 2007 | 62.25 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 62.49 Million INR | 94.78% |
| 2023 Q2 | 80.26 Million INR | -0.98% |
| 2023 Q3 | 76.6 Million INR | -4.56% |
| 2023 Q1 | 81.05 Million INR | 36.73% |
| 2023 FY | 271.24 Million INR | 1.57% |
| 2023 Q4 | 32.08 Million INR | -58.12% |
| 2022 Q4 | 59.28 Million INR | -27.3% |
| 2022 FY | 267.05 Million INR | 84.76% |
| 2022 Q1 | 49.32 Million INR | 48.57% |
| 2022 Q2 | 76.9 Million INR | 55.92% |
| 2022 Q3 | 81.54 Million INR | 6.03% |
| 2021 Q3 | 31.8 Million INR | -4.89% |
| 2021 Q4 | 33.2 Million INR | 4.38% |
| 2021 FY | 144.54 Million INR | 4.42% |
| 2021 Q1 | 46.09 Million INR | -20.73% |
| 2021 Q2 | 33.44 Million INR | -27.45% |
| 2020 Q1 | 26.96 Million INR | -4.14% |
| 2020 FY | 138.43 Million INR | 10.15% |
| 2020 Q3 | 20.62 Million INR | -36.91% |
| 2020 Q4 | 58.15 Million INR | 181.93% |
| 2020 Q2 | 32.69 Million INR | 21.23% |
| 2019 Q2 | 32.72 Million INR | -22.65% |
| 2019 FY | 125.67 Million INR | -0.57% |
| 2019 Q1 | 42.3 Million INR | 119.34% |
| 2019 Q3 | 22.51 Million INR | -31.19% |
| 2019 Q4 | 28.12 Million INR | 24.92% |
| 2018 Q4 | 19.28 Million INR | -37.05% |
| 2018 Q3 | 30.63 Million INR | -12.65% |
| 2018 FY | 126.39 Million INR | -14.36% |
| 2018 Q1 | 41.4 Million INR | -2.7% |
| 2018 Q2 | 35.07 Million INR | -15.29% |
| 2017 Q1 | 48.47 Million INR | 103.83% |
| 2017 Q4 | 42.55 Million INR | 17.19% |
| 2017 Q3 | 36.3 Million INR | 12.82% |
| 2017 FY | 147.58 Million INR | 36.64% |
| 2017 Q2 | 32.18 Million INR | -33.6% |
| 2016 Q1 | 30.4 Million INR | 88.83% |
| 2016 FY | 108 Million INR | -17.62% |
| 2016 Q4 | 23.78 Million INR | -7.68% |
| 2016 Q3 | 25.75 Million INR | -14.12% |
| 2016 Q2 | 29.99 Million INR | -1.34% |
| 2015 Q3 | 28.42 Million INR | -29.87% |
| 2015 Q4 | 16.09 Million INR | -43.37% |
| 2015 Q2 | 40.53 Million INR | -11.94% |
| 2015 FY | 131.1 Million INR | -1.33% |
| 2015 Q1 | 46.03 Million INR | 33.32% |
| 2014 Q4 | 34.53 Million INR | 20.91% |
| 2014 FY | 132.86 Million INR | -8.96% |
| 2014 Q1 | 36.48 Million INR | 63.04% |
| 2014 Q2 | 33.28 Million INR | -8.79% |
| 2014 Q3 | 28.56 Million INR | -14.19% |
| 2013 Q2 | 40.5 Million INR | -11.28% |
| 2013 FY | 145.93 Million INR | -0.29% |
| 2013 Q1 | 45.65 Million INR | 299.07% |
| 2013 Q3 | 37.38 Million INR | -7.7% |
| 2013 Q4 | 22.37 Million INR | -40.14% |
| 2012 Q1 | 45.93 Million INR | 129.36% |
| 2012 Q4 | 11.44 Million INR | -74.73% |
| 2012 FY | 146.35 Million INR | 58.05% |
| 2012 Q3 | 45.28 Million INR | 3.63% |
| 2012 Q2 | 43.69 Million INR | -4.87% |
| 2011 FY | 92.59 Million INR | 22.86% |
| 2011 Q4 | 20.02 Million INR | -10.56% |
| 2011 Q3 | 22.39 Million INR | 0.0% |
| 2010 FY | 75.37 Million INR | 8.52% |
| 2009 FY | 69.45 Million INR | -0.55% |
| 2008 Q4 | 18.32 Million INR | 0.0% |
| 2008 FY | 69.84 Million INR | 12.18% |
| 2007 FY | 62.25 Million INR | 0.0% |
| 2007 Q4 | 12.73 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -2485.882% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 98.0% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 74.137% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 32.227% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 26.726% |
| Sunil Healthcare Limited | 901.91 Million INR | 69.926% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -1375.612% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.518% |
| Zenith Healthcare Limited | 144.71 Million INR | -87.433% |
| Patidar Buildcon Limited | 2.3 Million INR | -11652.47% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 49.476% |
| Roopa Industries Limited | 715.53 Million INR | 62.092% |
| Smruthi Organics Limited | 1.27 Billion INR | 78.75% |
| Trident Lifeline Limited | 446.28 Million INR | 39.221% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -79.49% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 43.46% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 39.195% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 59.684% |
| PANJON LTD. | 125.52 Million INR | -116.097% |
| Tyche Industries Limited | 696.83 Million INR | 61.075% |
| Trimurthi Limited | 42.23 Million INR | -542.187% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 95.808% |
| Crestchem Limited | 212.56 Million INR | -27.608% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -4785.573% |
| Zenlabs Ethica Limited | 585.63 Million INR | 53.683% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 78.371% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 81.435% |
| Parmax Pharma Limited | 154.24 Million INR | -75.856% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 92.209% |
| Deccan Health Care Limited | 597.28 Million INR | 54.587% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 63.627% |
| Norris Medicines Limited | 56.35 Million INR | -381.309% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 94.148% |
| Veerhealth Care Limited | 142.13 Million INR | -90.839% |
| Makers Laboratories Limited | 1.03 Billion INR | 73.859% |
| Lactose (India) Limited | 1.13 Billion INR | 76.183% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 31.576% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 84.441% |
| Mercury Laboratories Limited | 755.59 Million INR | 64.101% |
| Gennex Laboratories Limited | 867.14 Million INR | 68.719% |
| PRAVEG LIMITED | 915.96 Million INR | 70.387% |
| Denis Chem Lab Limited | 1.67 Billion INR | 83.837% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 91.17% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 80.894% |
| Colinz Laboratories Limited | 70.29 Million INR | -285.864% |
| Godavari Drugs Limited | 1.56 Billion INR | 82.691% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -24161.807% |
| Zenotech Laboratories Limited | 368.08 Million INR | 26.309% |
| Panchsheel Organics Limited | 1.05 Billion INR | 74.221% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 78.455% |
| Vivanza Biosciences Limited | 278.89 Million INR | 2.741% |
| Phaarmasia Limited | 305.93 Million INR | 11.338% |
| Bharat Parenterals Limited | 2.59 Billion INR | 89.544% |
| Medi-Caps Limited | 265.63 Million INR | -2.113% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 25.225% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 84.028% |
| BDH Industries Limited | 858.31 Million INR | 68.398% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -163.659% |
| Coral Laboratories Limited | 836.6 Million INR | 67.578% |
| Concord Drugs Limited | 449.24 Million INR | 39.622% |
| Evoq Remedies Limited | 63.09 Million INR | -329.937% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 86.578% |
| Transchem Limited | 4.09 Million INR | -6515.782% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -78.598% |
| Parnax Lab Limited | 1.88 Billion INR | 85.626% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 0.63% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 73.495% |
| Cian Healthcare Limited | 616.95 Million INR | 56.035% |
| Trinity League India Limited | 2.95 Million INR | -9094.814% |
| Syschem (India) Limited | 2.33 Billion INR | 88.385% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 82.547% |
| Auro Laboratories Limited | 526.99 Million INR | 48.53% |